This statistic depicts the average body mass index (BMI) of U.S. adults aged 20 years and over as of 2016, by gender. According to the data, the average male BMI has increased from 27.8 in 1999-2000 to 29.1 as of 2015-2016.

Data on normal weight, overweight, and obesity among adults aged 20 and over by selected population characteristics. Please refer to the PDF or Excel version of this table in the HUS 2019 Data Finder (https://www.cdc.gov/nchs/hus/contents2019.htm) for critical information about measures, definitions, and changes over time.

SOURCE: NCHS, National Health and Nutrition Examination Survey. For more information on the National Health and Nutrition Examination Survey, see the corresponding Appendix entry at https://www.cdc.gov/nchs/data/hus/hus19-appendix-508.pdf.

Surveys in which U.S. adults report their current weight have shown that the share of those reporting they weigh 200 pounds or more has increased over the past few decades. In 2024, around 28 percent of respondents reported their weight as 200 pounds or more, compared to 15 percent in 1990. However, the same surveys show the share of respondents who report they are overweight has decreased compared to figures from 1990. What percentage of the U.S. population is obese? Obesity is an increasing problem in the United States that is expected to become worse in the coming decades. As of 2023, around one third of adults in the United States were considered obese. Obesity is slightly more prevalent among women in the United States, and rates of obesity differ greatly by region and state. For example, in West Virginia, around 41 percent of adults are obese, compared to 25 percent in Colorado. However, although Colorado is the state with the lowest prevalence of obesity among adults, a quarter of the adult population being obese is still shockingly high. The health impacts of being obese Obesity increases the risk of developing a number of health conditions including high blood pressure, heart disease, type 2 diabetes, and certain types of cancer. It is no coincidence that the states with the highest rates of hypertension are also among the states with the highest prevalence of obesity. West Virginia currently has the third highest rate of hypertension in the U.S. with 45 percent of adults with the condition. It is also no coincidence that as rates of obesity in the United States have increased so have rates of diabetes. As of 2022, around 8.4 percent of adults in the United States had been diagnosed with diabetes, compared to six percent in the year 2000. Obesity can be prevented through a healthy diet and regular exercise, which also increases overall health and longevity.

This statistic depicts the average body mass index (BMI) of U.S. females aged 20 years and over from 1999 to 2016, by ethnicity. According to the data, the average female BMI for those that identified as white was 27.6 in 1999-2000 and increased to 29.1 as of 2015-2016.

The spreadsheet contains regional level obesity trend data from the the HSE, BMI data from Understanding Society, and adjusted prevalence of underweight, healthy weight, overweight, and obesity by local authority from the Active People Survey.

Understanding Society data shows the percentage of the population aged 10 and over by their Body Mass Index Classification, covering underweight, normal weight, overweight, and three classes of obesity.

Questions on self-reported height and weight were added to the Sport England Active People Survey (APS) in January 2012 to provide data for monitoring excess weight (overweight including obesity, BMI ≥25kg/m2) in adults (age 16 and over) at local authority level for the Public Health Outcomes Framework (PHOF).

Health Survey for England (HSE) results at a national level are available on the NHS Information Centre website.

Other NHS indicators on obesity are available for Strategic Health Authorities (SHA).

Relevant links: http://discover.ukdataservice.ac.uk/series/?sn=2000053

http://www.noo.org.uk/visualisation/adult_obesity

West Virginia, Mississippi, and Arkansas are the U.S. states with the highest percentage of their population who are obese. The states with the lowest percentage of their population who are obese include Colorado, Hawaii, and Massachusetts. Obesity in the United States Obesity is a growing problem in many countries around the world, but the United States has the highest rate of obesity among all OECD countries. The prevalence of obesity in the United States has risen steadily over the previous two decades, with no signs of declining. Obesity in the U.S. is more common among women than men, and overweight and obesity rates are higher among African Americans than any other race or ethnicity. Causes and health impacts Obesity is most commonly the result of a combination of poor diet, overeating, physical inactivity, and a genetic susceptibility. Obesity is associated with various negative health impacts, including an increased risk of cardiovascular diseases, certain types of cancer, and diabetes type 2. As of 2022, around 8.4 percent of the U.S. population had been diagnosed with diabetes. Diabetes is currently the eighth leading cause of death in the United States.

This report presents information on obesity, physical activity and diet drawn together from a variety of sources for England. More information can be found in the source publications which contain a wider range of data and analysis. Each section provides an overview of key findings, as well as providing links to relevant documents and sources. Some of the data have been published previously by NHS Digital. A data visualisation tool (link provided within the key facts) allows users to select obesity related hospital admissions data for any Local Authority (as contained in the data tables), along with time series data from 2013/14. Regional and national comparisons are also provided. The report includes information on: Obesity related hospital admissions, including obesity related bariatric surgery. Obesity prevalence. Physical activity levels. Walking and cycling rates. Prescriptions items for the treatment of obesity. Perception of weight and weight management. Food and drink purchases and expenditure. Fruit and vegetable consumption. Key facts cover the latest year of data available: Hospital admissions: 2018/19 Adult obesity: 2018 Childhood obesity: 2018/19 Adult physical activity: 12 months to November 2019 Children and young people's physical activity: 2018/19 academic year

In 2023, it was estimated that around 37 percent of adults with an annual income of less than 15,000 U.S. dollars were obese, compared to 29 percent of those with an annual income of 75,000 dollars or more. This statistic shows the percentage of U.S. adults who were obese in 2023, by income.

These data are from the 2013 California Dietary Practices Surveys (CDPS), 2012 California Teen Eating, Exercise and Nutrition Survey (CalTEENS), and 2013 California Children’s Healthy Eating and Exercise Practices Surveys (CalCHEEPS). These surveys have been discontinued. Adults, adolescents, and children (with parental assistance) were asked for their current height and weight, from which, body mass index (BMI) was calculated. For adults, a BMI of 30.0 and above is considered obese. For adolescents and children, obesity is defined as having a BMI at or above the 95th percentile, according to CDC growth charts.

The California Dietary Practices Surveys (CDPS), the California Teen Eating, Exercise and Nutrition Survey (CalTEENS), and the California Children’s Healthy Eating and Exercise Practices Surveys (CalCHEEPS) (now discontinued) were the most extensive dietary and physical activity assessments of adults 18 years and older, adolescents 12 to 17, and children 6 to 11, respectively, in the state of California. CDPS and CalCHEEPS were administered biennially in odd years up through 2013 and CalTEENS was administered biennially in even years through 2014. The surveys were designed to monitor dietary trends, especially fruit and vegetable consumption, among Californias for evaluating their progress toward meeting the Dietary Guidelines for Americans and the Healthy People 2020 Objectives. All three surveys were conducted via telephone. Adult and adolescent data were collected using a list of participating CalFresh households and random digit dial, and child data were collected using only the list of CalFresh households. Older children (9-11) were the primary respondents with some parental assistance. For younger children (6-8), the primary respondent was parents. Data were oversampled for low-income and African American to provide greater sensitivity for analyzing trends among the target population. Wording of the question used for these analyses varied by survey (age group). The questions were worded are as follows: Adult:1) How tall are you without shoes?2) How much do you weigh?Adolescent:1) About how much do you weigh without shoes?2) About how tall are you without shoes? Child:1) How tall is [child's name] now without shoes on?2) How much does [child's name] weigh now without shoes on?

This statistic depicts the average body mass index (BMI) of U.S. females aged 20 years and over from 1999 to 2016, by age. According to the data, the average female BMI for those aged 40-59 years was 29 in 1999-2000 and increased to 30.4 as of 2015-2016.

Health, social and economic characteristics of obese (BMI≥30 kg/m2) vs. normal weight (18,5 kg/m2 ≤BMI

In 2023, Black adults had the highest obesity rates of any race or ethnicity in the United States, followed by American Indians/Alaska Natives and Hispanics. As of that time, around 42 percent of all Black adults were obese. Asians/Pacific Islanders had by far the lowest obesity rates. Obesity in the United States Obesity is a present and growing problem in the United States. An astonishing 33 percent of the adult population in the U.S. is now considered obese. Obesity rates can vary substantially by state, with around 41 percent of the adult population in West Virginia reportedly obese, compared to 25 percent of adults in Colorado. The states with the highest rates of obesity include West Virginia, Mississippi, and Arkansas. Diabetes Being overweight and obese can lead to a number of health problems, including heart disease, cancer, and diabetes. Being overweight or obese is one of the most common causes of type 2 diabetes, a condition in which the body does not use insulin properly, causing blood sugar levels to rise. It is estimated that just over eight percent of adults in the U.S. have been diagnosed with diabetes. Diabetes is now the eighth leading cause of death in the United States, accounting for three percent of all deaths.

This dataset is about book subjects and is filtered where the books is Obesity in America, 1850-1939 : a history of social attitudes and treatment, featuring 10 columns including authors, average publication date, book publishers, book subject, and books. The preview is ordered by number of books (descending).

The Health Examination Survey 2018-2019 of the CUORE Project is coordinated by the Department of Cardiovascular, Endocrine-metabolic Diseases and Aging of the Istituto Superiore di Sanità

The objectives of the survey, addressed to the general adult population (35-74 years), are to:

1. estimate the distribution of risk factors (arterial blood pressure, heart rate, weight, height, body mass index, waist and hips circumference);
2. study the distribution of life habits (physical activity, smoking habits, diet, alcohol consumption);
3. estimate the prevalence of conditions at risk (arterial hypertension, overweight and obesity, smoking habits);
4. evaluate the temporal trend of risk factors distribution (arterial blood pressure, heart rate, weight, height, body mass index, waist circumference and hips);
5. evaluate the temporal trend of life habits distribution (physical activity, smoking habits, diet, alcohol consumption);
6. evaluate the temporal trend of the prevalence of conditions at risk (arterial hypertension, overweight and obesity, smoking habits);
7. monitor national lifestyles campaigns, in particular estimate the average daily consumption of sodium, potassium and iodine per capita, as a result of the “Guadagnare Salute” program of the Ministry of Health;
8. evaluate physical performance, attention and memory in the elderly population (65-74 years);
9. study the degree of health literacy;

The survey is conducted in several Italian regions, between North, Central and South; in each region, a sample of 200 people is enrolled, stratified by gender and age group, randomly extracted from the general population residing in a selected municipality. For each age group (35-44, 45-54, 55-64, 65-74) and sex, 25 people are drawn.

Mean Neutrophil, Lymphocyte, and NLR values according to demographic and clinical characteristics for children age 2–18 years (n = 5286) - NHANES data set. (DOCX)

In 2023, it was estimated that around 32 percent of men and 34 percent of women in the U.S. were obese. This statistic shows the percentage of adults in the United States who were obese in 2023, by gender.

Abstract copyright UK Data Service and data collection copyright owner.

The National Child Measurement Programme (NCMP) was first established in 2005. It is an annual programme which measures the height and weight of children in Reception and Year 6 within state maintained schools. Some independent and special schools also choose to participate.

The measurement process is overseen by trained healthcare professionals in schools and not shared with school staff or pupils. Data are captured and validated by Primary Care Trusts (PCTs). The Health and Social Care Information Centre (HSCIC) (prior to 1 April 2013 the NHS Information Centre for Health and Social Care (NHS IC)) then collates the data at a national level, conducts further validation and analysis, and publishes an annual report. The National Obesity Observatory (NOO) also publish detailed analysis of the NCMP dataset annually. The validated national NCMP dataset is shared with Public Health Observatories (PHOs) in accordance with the terms of a data sharing agreement. The PCTs also undertake additional analyses at regional and local level to inform the work of the NHS and local authorities on the healthy weight agenda.

The NCMP was set up in line with the Government's strategy to tackle obesity and to:

• inform local planning and delivery of services for children
• gather population-level data to allow analysis of trends in growth patterns and obesity
• increase population and professional understanding of weight issues in children
• be a vehicle for engaging with children and families about healthy lifestyles and weight issues

Further information can be found at the Health and Social Care Information Centre National Child Measurement Programme webpage.


Main Topics:
The database includes information on anthropometric measurements of Reception Year and Year 6 children in schools in England, collected during the school year as part of the NCMP.

The database comprises tables covering BMI classification (every pupil is classified into only one BMI category); Government Office Region codes; a range of NCMP data at Primary Care Trust level; a range of NCMP data at record level; information on primary schools that did and did not participate in the NCMP Programme; a description of the school type codes; a range of NCMP data at SHA level; and information on urban/rural indicators. For a full list of fields, and descriptions within the database please refer to the metadata documentation. The database is a ‘reduced’ version of the full NCMP dataset to ensure that the risk of disclosure is minimal. See documentation for details of omitted fields.

Standard Measures:
Since children’s height and weight are dependent on age and sex, height and weight measurements must be standardised to take these factors into account. The standardised value is a 'z-score' and indicates how far, and in what direction, the measurement deviates from the average (mean) for that age and sex. A formula ('Cole's method') is used to standardise height, weight and BMI (see Cole, T. (1997) 'Growth monitoring with the British 1990 growth reference', Archives of Disease in Childhood, 76(1), pp.47–49). For every measurement, age (in months) and sex, there is a growth curve based on the UK 1990 Growth Reference. This provides the values required by the formula to allow the height, weight and BMI z-score to be calculated. The z-scores are converted to p-scores and allow every child to be assigned to a BMI classification using defined cut-offs. Please see the 'NCMP Guidance for Analysis' in the documentation for further details.

The indicator measures the share of obese people based on their body mass index (BMI). BMI is defined as the weight in kilos divided by the square of the height in meters. People aged 18 years or over are considered obese with a BMI equal or greater than 30. Other categories are: underweight (BMI less than 18.5), normal weight (BMI between 18.5 and less than 25), and pre-obese (BMI between 25 and less than 30). The category overweight (BMI equal or greater than 25) combines the two categories pre-obese and obese. Copyright notice and free re-use of data on: https://ec.europa.eu/eurostat/about-us/policies/copyright

*p = 0.04;#p

Maternal obesity has been associated with a higher risk of pregnancy-related complications in mothers and offspring; however, effective interventions have not yet been developed. We tested two common interventions, calorie restriction and pravastatin administration, during pregnancy in a rhesus macaque model with the hypothesis that these interventions would normalize metabolic dysregulation in pregnant mothers leading to an improvement in infant metabolic and cognitive/social development. A total of 19 obese mothers were assigned to either one of the two intervention groups (n=5 for calorie restriction; n=7 for pravastatin) or an obese control group (n=7) with no intervention, and maternal gestational samples and postnatal infant samples were compared with lean control mothers (n=6). Gestational calorie restriction normalized one-carbon metabolism dysregulation in obese mothers but altered energy metabolism in their offspring. Although administration of pravastatin during pregnancy tended to normalize blood cholesterol in the mothers, it potentially impacted the gut microbiome and kidney function of their offspring. In the offspring, both calorie restriction and pravastatin administration during pregnancy tended to normalize the activity of AMPK in the brain at 6 months, and while results of the Visual Paired-Comparison test, which measures infant recognition memory, were not significantly impacted by either of the interventions, gestational pravastatin administration, but not calorie restriction, tended to normalize anxiety assessed by the Human Intruder test. Although the two interventions tested in a non-human primate model led to some improvements in metabolism and/or infant brain development, negative impacts were also found in both mothers and infants. Our study emphasizes the importance of assessing gestational interventions for maternal obesity on both maternal and offspring long-term outcomes. Methods Study population Pregnant female rhesus macaques (Macaca mulatta) from an indoor breeding colony at the California National Primate Research Center with appropriate social behavior and previous successful pregnancies were enrolled. Animal handling was approved by the UC Davis Institutional Animal Care and Use Committee (IACUC) (#19299). A qualitative real-time PCR assay (Jimenez & Tarantal, 2003) was used to identify mothers with male fetuses to include in this study. Since obesity is defined as subjects with body fat above 30% for women, according to guidelines from the American Society of Bariatric Physicians, American Medical Association, and in some publications (Okorodudu et al., 2010; Shah & Braverman, 2012), a Body Condition Score (BCS) of 3.5 (32.8 % body fat on average (Summers et al., 2012)) was used as the cutoff. Therefore, mothers with BCS of 3.5 and above were categorized as obese. Obese mothers were randomly assigned to the Obese Control (OC) group, OR group (received calorie Restriction), or OP group (received Pravastatin). Mothers with BCS of 2.5 and below were assigned to the Lean Control (LC) group. The unbalanced sample size was because some mothers were removed from the analyses due to fetal deaths for unknown reasons, misidentification of a female fetus, different timing for study enrollment, or technical issues upon collecting samples. The number of animals was six for the LC, seven for the OC, five for the OR, and seven for the OP groups. Feeding, rearing, and interventions Adult female animals were provided monkey diet (High Protein Primate Diet Jumbo #5047; LabDiet, St. Louis, MO, USA) twice a day between 6–9 am and 1–3 pm. The calories were provided as 56% from carbohydrates, 30% from protein, and 13% from. Mothers in the LC, OC, and OP groups were fed nine biscuits twice a day once pregnancy was confirmed. Mothers in the OR group received a restricted supply of food once the pregnancy was detected and was maintained throughout pregnancy. The food restriction was set such that the average total weight increase would be 8% body weight from the last day before conception because the recommended total weight gain in the 2nd and 3rd trimesters is 5-9 kg for the average US woman with obesity who weighs 80 kg and is 1.6 m in height (Body Mass Index of 30), according to the Institute of Medicine 2009 guidelines (Institute of Medicine and National Research Council, 2009). During nursing of infants older than 4 months, all mothers were provided twelve biscuits. Fresh produce was provided biweekly, and water was provided ad libitum for all mothers. Mothers in the OP group were given pravastatin sodium (ApexBio Technology, Houston, TX, USA) at 20 mg/kg body weight prepared in a neutralized syrup (20 mg/mL sodium bicarbonate dissolved in a fruit-flavored syrup (Torani, San Leandro, CA, USA)) once a day from the time pregnancy was confirmed until delivery. The caloric value of the administration was made so as not to influence body weight or skew nutritional value of the diet among all treatment groups. Both interventions were applied only during gestation. Although most mothers were allowed to deliver naturally, cesarean delivery was performed for fetal indications when recommended by veterinarians (2 for each of the LC and OC groups, and 1 for the OP group). These mothers did not accept their infant following birth, so foster mothers were provided. Sample Collection and pre-processing prior to sample storage The animal caretakers and researchers who collected samples were blinded for group assignment by coding all animals by IDs. The collected biological samples were randomized by using random numbers and the group assignment was blinded during the data collection. Both mothers (during pregnancy) and infants were weighed every week. One day before sample collection, food was removed 30 min after the afternoon feeding, and biological samples were collected prior to the morning feeding. To collect biological samples, animals were anesthetized using 5–30 mg/kg ketamine or 5–8 mg/kg telazol. Both maternal and infant blood was collected using 5 mL lavender top (EDTA) tubes (Monoject, Cardinal Health, Dublin, OH, USA) and urine was collected from the bladder by ultrasound-guided transabdominal cystotomy using a 22-gauge needle and stored in a 15 mL Falcon tube. A placental sample was collected at GD150 transabdominally under ultrasound guidance using an 18-gauge needle attached to a sterile syringe. Sample processing was as previously described in (Hasegawa et al., 2022). Necropsy was conducted between 9:30 am–1:30 pm. First, infants at the age of PD180 were fasted and anesthetized with ketamine, and plasma and urine were collected. Then, euthanasia was performed with 120 mg/kg pentobarbital, followed by heparin injection, clamping of the descending aorta, and flushing with saline until clear. The kidney and brain (amygdala, hippocampus, hypothalamus, and prefrontal cortex) were collected, weighed, and immediately frozen on dry ice or liquid nitrogen to store at -80 °C until further analyses. Metabolite extraction and analysis by 1H NMR, and measurement of insulin, cholesterol, cytokine, and cortisol Detailed procedures were previously described (Hasegawa et al., 2022). Briefly, plasma and urine samples were filtered using Amicon Ultra Centrifugal Filter (3k molecular weight cutoff; Millipore, Billerica, MA, USA), and the supernatant was used for analysis. For both the placental and brain tissue samples, polar metabolites were extracted using our previously reported method (Hasegawa et al., 2020). A total of 180 μL of sample (tissue extract or filtered urine or serum) was transferred to 3 mm Bruker NMR tubes (Bruker, Billerica, MA, USA). Within 24 h of sample preparation, all 1H NMR spectra were acquired using the noesypr1d pulse sequence on a Bruker Avance 600 MHz NMR spectrometer (Bruker, Billerica, MA, USA) (O’Sullivan et al., 2013). Chenomx NMRSuite (version 8.1, Chenomx Inc., Edmonton, Canada) (Weljie et al., 2006) was used to identify and quantify metabolites. Heparin-treated plasma samples were used to measure insulin and 17 cytokines and chemokines (hs-CRP, Granulocyte-macrophage colony-stimulating factor, IFN-γ, TNF-α, transforming growth factor-α, monocyte chemoattractant protein-1, macrophage inflammatory protein-1β (MIP-1β), and interleukin (IL)-1β, IL-1 receptor antagonist (IL-1ra), IL-2, IL-6, IL-8, IL-10, IL-12/23 p40, IL-13, IL-15, and IL-17A) using a multiplex Bead-Based Kit (Millipore) on a Bio-Plex 100 (Bio-rad, Hercules, CA) following the manufacturer’s protocol. For each sample, a minimum of fifty beads per region were collected and analyzed with Bio-Plex Manager software using a 5-point standard curve with immune marker quantities extrapolated based on the standard curve. Two samples were removed for analysis of TNF-α and IL-1ra as technical errors (both from Animal ID 1132103: 895.2 and 1115.1 pg/mL at gestational days (GD) 90; 510.8 and 617.2 pg/mL at GD120, respectively). Plasma cholesterol level was measured by Clinical Laboratory Diagnostic Product (OSR6116) on Beckman Coulter AU480 (Beckman Coulter, Brea, CA). Infant plasma cortisol level at PD110 was assessed as previously described (Vandeleest et al., 2019; Walker et al., 2018). In short, infants were transferred to a test room at 9 am and blood was drawn at 11 am (Sample 1), followed by another blood collection at 4 pm (Sample 2) and intramuscular injection of 500 μg/kg dexamethasone (Dex) (American Regent Laboratories, Inc., Shirley, NY). On the next day, a blood sample was collected at 8:30 am (Sample 3), and then 2.5 IU of adrenocorticotropic hormone (Amphastar Pharmaceuticals, Inc., Rancho Cucamonga, CA) was injected intramuscularly. The last blood was collected (Sample 4) 30 min after adrenocorticotropic hormone injection. The collected blood samples were processed and stored, and cortisol concentration was assessed by a chemiluminescent assay on the ADVIA Centaur CP platform